ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 153 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $132,000 | -7.7% | 4,580 | +2.2% | 0.00% | -20.0% |
| Q3 2016 | $143,000 | -12.3% | 4,480 | -10.6% | 0.01% | -16.7% |
| Q2 2016 | $163,000 | +17.3% | 5,010 | +0.8% | 0.01% | 0.0% |
| Q1 2016 | $139,000 | -28.4% | 4,969 | -8.5% | 0.01% | -33.3% |
| Q4 2015 | $194,000 | +30.2% | 5,430 | +20.7% | 0.01% | -25.0% |
| Q3 2015 | $149,000 | -28.7% | 4,500 | -10.0% | 0.01% | -20.0% |
| Q2 2015 | $209,000 | -14.0% | 5,000 | -32.9% | 0.02% | -11.8% |
| Q1 2015 | $243,000 | 0.0% | 7,450 | -2.6% | 0.02% | -34.6% |
| Q4 2014 | $243,000 | +84.1% | 7,650 | +43.0% | 0.03% | +62.5% |
| Q3 2014 | $132,000 | +9.1% | 5,350 | 0.0% | 0.02% | 0.0% |
| Q2 2014 | $121,000 | -53.5% | 5,350 | -50.0% | 0.02% | -15.8% |
| Q1 2014 | $260,000 | +94.0% | 10,700 | +100.0% | 0.02% | -5.0% |
| Q4 2013 | $134,000 | -13.0% | 5,350 | -4.5% | 0.02% | -25.9% |
| Q3 2013 | $154,000 | +8.5% | 5,600 | -28.2% | 0.03% | -3.6% |
| Q2 2013 | $142,000 | – | 7,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |